Get the Daily Brief
Latest Biotech News
AI and Machine Learning Propel Advances in Cancer Detection, Drug Design, and Educational Tools
Artificial intelligence continues to revolutionize biotech, from improving early cancer detection with novel decision-tree-based MIGHT algorithms to enhancing drug-target affinity predictions via...
Immunology and Inflammation: New Mechanisms and Therapeutic Targets
Recent research illuminates novel immune pathways shaping disease outcomes. A study reveals U2AF1 mutations significantly alter erythroid differentiation and therapy response, impacting...
Organ Transplantation Advancements: Machine Perfusion, Immune Therapies and Biopsy Standardization
Organ transplantation continues to progress with new preservation and evaluation techniques. Normothermic machine perfusion enhances liver graft viability from circulatory death donors, improving...
Metabolic and Cardiovascular Innovations: Gene Targets and Drug Effects
Groundbreaking work expands understanding of cardiovascular and metabolic diseases. The adipokine hypothesis links alterations in internal fat biology to heart failure with preserved ejection...
Reproductive Health Breakthroughs: Oocyte Biology and Fertility Preservation
New insights into female reproductive biology and therapeutic options emerge. Kuntai capsules activate AMPK-associated autophagy to enhance ovarian function, highlighting traditional medicine...
Artificial Intelligence Enhances Medical Imaging and Analysis
AI-driven methodologies further medical imaging capabilities with clinical utility. XGBoost models accurately distinguish brain tumors from metastases using radiomics, enabling tailored...
Emerging Biomarkers and Molecular Discoveries in Neurodegeneration and Cancer
Studies uncover molecular markers influencing disease progression and therapeutic resistance. Elevated hexosylceramides provoke Parkinson’s disease-related gene expression changes mimicking immune...
FDA Clears Sanofi’s BTK Inhibitor for Rare Disease: Rilzabrutinib Approved
The FDA has approved rilzabrutinib, a BTK inhibitor acquired by Sanofi through the $3.7 billion acquisition of Principia Biopharma. The drug is indicated for immune thrombocytopenia, a rare...
First Pig-to-Human Lung Transplant Survives Nine Days in Breakthrough Trial
Chinese researchers at Guangzhou Medical University successfully transplanted a genetically engineered pig lung into a brain-dead human recipient, marking the first case of a pig lung functioning...
Off-the-Shelf CAR-NKT Cell Therapy Targets Metastatic Kidney Cancer
UCLA researchers developed AlloCAR70-NKT, an allogeneic cell therapy engineered to combat metastatic renal cell carcinoma. This innovative immunotherapy utilizes CD70-directed CAR-engineered...
Raina Biosciences Launches AI-Driven mRNA Therapeutics Platform: GEMORNA Unveiled
Raina Biosciences has introduced GEMORNA, a deep generative AI platform designed to engineer mRNA sequences with enhanced translational efficiency and stability for therapeutic applications....
Novartis' Leqvio Shows Lipid Level and Muscle Pain Improvement in High-Risk Patients
Data presented at the European Society of Cardiology meeting demonstrated that Novartis' cholesterol-lowering medication Leqvio rapidly improved lipid profiles in high-risk patients when added to...
Mid-Stage Data Question Efficacy of Alnylam’s Hypertension Therapy Zilebesiran
Alnylam Pharmaceuticals reported that their RNA interference drug zilebesiran did not achieve a statistically significant blood pressure reduction in a key Phase 2 trial involving patients with...
FDA Approves Eisai and Biogen’s Subcutaneous Alzheimer’s Drug Leqembi
The FDA has approved a new subcutaneous formulation of Leqembi, Eisai and Biogen’s Alzheimer's treatment, enhancing administration options for patients suffering from early-stage disease. This...
NeoGenomics Wins Patent Litigation, Clearing Path for Radar ST MRD Assay
A US district court ruled in favor of NeoGenomics, invalidating two of Natera's patents related to minimal residual disease (MRD) detection assays. This ruling allows NeoGenomics to market its...
Machine Learning MIGHT Algorithm Enhances Early Cancer Detection Tests
Johns Hopkins University researchers developed MIGHT, a novel AI method optimizing sensitivity and specificity in early cancer screening. Unlike typical accuracy-focused algorithms, MIGHT balances...
Gut-Brain Axis Implicated in Alzheimer’s: Immune Cells Migrate from Colon to Brain
Buck Institute researchers discovered in an Alzheimer's disease mouse model that colonic immune cells, particularly CXCR4+ IgA-secreting B cells, migrate to the brain, potentially contributing to...
RSV Vaccine Shows Durable Protection in Older Adults
A pivotal study published in JAMA reports that a single dose of a respiratory syncytial virus (RSV) vaccine substantially reduces severe illness and hospitalization among older adults across two...
Advances in Organ Transplantation: Machine Perfusion and Kidney Biopsy Standardization
Organ transplantation continues to benefit from technological and procedural breakthroughs. Normothermic Regional Perfusion (NRP) is emerging as a transformative technique in liver...
AI and Machine Learning Transform Cancer Diagnostics and Therapeutics
Artificial intelligence (AI) and machine learning are reshaping oncology research and patient care. Johns Hopkins University introduced MIGHT, a novel AI method optimizing early cancer detection...